LENSAR, Inc.
NASDAQ:LNSRMedical - Devices
-$0.51 today
- Market cap
- $59.63M
- Beta
- 0.87
- P/E (TTM)
- 2.4
- EPS (TTM)
- $2.42
Volume 0.06M
Average 0.09M
LNSR Deferred Revenue
Payments received for goods or services the company will deliver within the next year.
LENSAR, Inc.NASDAQ: LNSR
Deferred Revenue · Q1 FY2026 · quarter ended Mar 2026
Deferred revenue rises 51.2% from a year ago
Deferred revenue stood at $3.01M at the end of Q1 FY2026, up 51.2% from a year earlier and down 2.0% from the prior quarter. Over 3 fiscal years it compounded at +58.8% a year.
Context
- Deferred revenue amounted to 4.5% of total assets at the end of Q1 FY2026, up 1.8 pp from a year earlier.
- Deferred revenue increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether deferred revenue keeps rising in the next quarterly balance sheet after a +51.2% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Deferred Revenue history
USD · from the balance sheet
- Latest · FY2025
- 3.07M USD
- Year-over-year change
- +83.3%
- 4-year CAGR
- +35.8%
| Period | Period end | Deferred Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 3.07M | +83.3% |
| FY2024 | 2024-12-31 | 1.68M | +24.3% |
| FY2023 | 2023-12-31 | 1.35M | +75.7% |
| FY2022 | 2022-12-31 | 768K | -15.0% |
| FY2021 | 2021-12-31 | 904K | — |
Deferred Revenue vs competitors
How LNSR compares with its peers on the latest reported figures
- LNSR's Mar 2026 deferred revenue of $3.01M is the 3rd highest of the 10 companies compared; the peer median is $229K.
- Its year-over-year change of +51.2% is the 2nd highest of 5, against a peer median of -6.1%.
- Deferred revenue amounts to 4.5% of total assets for LNSR, versus a peer median of 0.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $6.63M | +8.9% | +0.2% | 10.6% | |
| Mar 2026 | $3.27M | -21.1% | — | 1.7% | |
| Mar 2026 | $3.01M | +51.2% | +58.8% | 4.5% | |
| Mar 2026 | $2.41M | +65.3% | — | 2.8% | |
| Mar 2026 | $465.53K | -26.8% | — | 0.6% | |
| Mar 2026 | $229K | — | — | 0.1% | |
AVRAnteris Technologies Global Corp. | Mar 2026 | $0 | — | — | 0.0% |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding LNSR) | $229K | -6.1% | +0.2% | 0.1% | |
Competitors are the stored peer set for LNSR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 31.64M | 14.67M | 20.62M | 16.26M | 12.97M |
| Short-term Investments | 0 | 0 | 3.44M | 6.19M | 5M |
| Net Receivables | 4.99M | 6.24M | 4.32M | 6.48M | 6.38M |
| Inventory | 6.49M | 11.74M | 15.69M | 11.43M | 21.52M |
| Other Current Assets | 0 | 1.06M | 2.37M | 1.62M | 896K |
| Total Current Assets | 44.81M | 33.72M | 46.44M | 41.98M | 46.77M |
| Property, Plant & Equipment (Net) | 7.45M | 6.88M | 10.28M | 664K | 505K |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 10.87M | 12.12M | 11.03M | 6.11M | 5.19M |
| Long-term Investments | 0 | 442K | 492K | 1.16M | 0 |
| Tax Assets | 0 | (442K) | 0 | 0 | 0 |
| Other Non-current Assets | 3.34M | 3.13M | 1.35M | 16.38M | 18.96M |
| Total Non-current Assets | 21.65M | 22.13M | 23.14M | 24.32M | 24.66M |
| Total Assets | 66.47M | 55.84M | 69.59M | 66.3M | 71.43M |
| Account Payables | 2.69M | 5.42M | 4.01M | 6M | 18.98M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 904K | 768K | 1.35M | 1.68M | 3.07M |
| Other Current Liabilities | 3.38M | 3.52M | 4.01M | 5M | 15.05M |
| Total Current Liabilities | 8.71M | 11.42M | 11.63M | 15M | 40.57M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 69K | 167K | 9.03M | 30.56M | 54.89M |
| Total Non-current Liabilities | 2.87M | 2.44M | 10.78M | 32.65M | 56.88M |
| Total Liabilities | 11.59M | 13.86M | 22.41M | 47.65M | 97.45M |
| Common Stock | 110K | 111K | 113K | 116K | 120K |
| Retained Earnings | (77.59M) | (97.51M) | (111.89M) | (143.3M) | (177.58M) |
| Accumulated OCI | 0 | 0 | 4K | 6K | 4K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 54.88M | 41.98M | 47.18M | 18.65M | (26.02M) |
| Total Debt | 3.32M | 2.8M | 2.31M | 2.61M | 2.74M |
| Net Debt | (28.32M) | (11.87M) | (18.31M) | (13.65M) | (10.24M) |
LENSAR, Inc.
NASDAQ:LNSR
Intrinsic Alpha fair value
Locked
Current Price
$4.85
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.